News Releases – News & Events | Oncolytics Biotech Inc.

News Releases

Latest News Release

Dec 13, 2012

Oncolytics Biotech Inc. Announces Positive Top Line REOLYSIN^® Data for First Endpoint in Randomized Phase III Study in Head and Neck Cancers

Nov 12, 2012

Oncolytics Biotech Inc. Announces Addition to Senior Management Team

Nov 9, 2012

Oncolytics Biotech^® Inc. Collaborators Present Positive REOLYSIN^® Trial Results and Research at EORTC-NCI-AACR Symposium

Nov 8, 2012

Oncolytics Biotech^® Inc. Announces Third Quarter 2012 Results

Oct 24, 2012

Oncolytics Biotech^® Inc. Completes Patient Enrollment in U.S. Phase II Clinical Trial Investigating REOLYSIN^® in Combination with Gemcitabine in Patients with Advanced or Metastatic Pancreatic Cancer

Sep 28, 2012

Oncolytics Biotech Inc. Announces the Appointment of Dr. Alan J. Tuchman as Chief Medical Officer

Sep 13, 2012

Oncolytics Biotech^® Inc. Meets Primary Endpoint for First Stage of U.S. Phase 2 Squamous Cell Lung Cancer Clinical Trial

Sep 12, 2012

Oncolytics Biotech Inc. Provides Update on Phase III Study of REOLYSIN^® in Head and Neck Cancers

1
2
3
4